FDA to review risks of antidepressants in adults

BMJ 2004; 329 doi: (Published 07 October 2004) Cite this as: BMJ 2004;329:816
  1. Jeanne Lenzer
  1. New York

    The US Food and Drug Administration (FDA) announced last week that it will examine whether antidepressants pose a similar risk of increased suicidal thoughts among adults as they do for children, by reanalysing data for adults.

    “Our first priority with regard to the adult data is to finish our analysis of the adult completed …

    View Full Text

    Sign in

    Log in through your institution

    Free trial

    Register for a free trial to to receive unlimited access to all content on for 14 days.
    Sign up for a free trial